[go: up one dir, main page]

ITMI912207A1 - Materiale spugnoso essenzialmente costituito da acido ialuronico, o suoi derivati - Google Patents

Materiale spugnoso essenzialmente costituito da acido ialuronico, o suoi derivati

Info

Publication number
ITMI912207A1
ITMI912207A1 IT002207A ITMI912207A ITMI912207A1 IT MI912207 A1 ITMI912207 A1 IT MI912207A1 IT 002207 A IT002207 A IT 002207A IT MI912207 A ITMI912207 A IT MI912207A IT MI912207 A1 ITMI912207 A1 IT MI912207A1
Authority
IT
Italy
Prior art keywords
derivatives
hyaluronic acid
essentially constituted
spongy material
material essentially
Prior art date
Application number
IT002207A
Other languages
English (en)
Inventor
Alberto Perbellini
Aurelio Romeo
Gino Toffano
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of ITMI912207A0 publication Critical patent/ITMI912207A0/it
Priority to ITMI912207A priority Critical patent/IT1251151B/it
Priority to EP92113212A priority patent/EP0526865A1/en
Priority to TW081106130A priority patent/TW215903B/zh
Priority to KR1019920013969A priority patent/KR930003921A/ko
Priority to BR929203032A priority patent/BR9203032A/pt
Priority to MX9204517A priority patent/MX9204517A/es
Priority to JP4207881A priority patent/JPH05255124A/ja
Priority to AU20840/92A priority patent/AU654027B2/en
Priority to US07/925,073 priority patent/US5503848A/en
Priority to CA002075340A priority patent/CA2075340A1/en
Publication of ITMI912207A1 publication Critical patent/ITMI912207A1/it
Application granted granted Critical
Publication of IT1251151B publication Critical patent/IT1251151B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2201/00—Foams characterised by the foaming process
    • C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
    • C08J2201/05—Elimination by evaporation or heat degradation of a liquid phase
    • C08J2201/0504—Elimination by evaporation or heat degradation of a liquid phase the liquid phase being aqueous
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/07—Microporous membranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
ITMI912207A 1991-08-05 1991-08-05 Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati IT1251151B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ITMI912207A IT1251151B (it) 1991-08-05 1991-08-05 Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
EP92113212A EP0526865A1 (en) 1991-08-05 1992-08-03 Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery
TW081106130A TW215903B (it) 1991-08-05 1992-08-03
BR929203032A BR9203032A (pt) 1991-08-05 1992-08-04 Material esponjoso de liberacao lenta,processo para preparar o mesmo,preparacoes farmaceuticas e processo terapeutico
KR1019920013969A KR930003921A (ko) 1991-08-05 1992-08-04 필수적으로 히알루론산 또는 이의 유도체로 이루어진 해면상 물질, 및 현미수술시 이의 용도
MX9204517A MX9204517A (es) 1991-08-05 1992-08-04 Material esponjoso formado esencialmente por acido hialuronico o sus derivados, y su uso en microcirugia.
JP4207881A JPH05255124A (ja) 1991-08-05 1992-08-04 ヒアルロン酸又はその誘導体から実質的に構成されるスポンジ物質
AU20840/92A AU654027B2 (en) 1991-08-05 1992-08-05 Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery
US07/925,073 US5503848A (en) 1991-08-05 1992-08-05 Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery
CA002075340A CA2075340A1 (en) 1991-08-05 1992-08-05 Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912207A IT1251151B (it) 1991-08-05 1991-08-05 Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati

Publications (3)

Publication Number Publication Date
ITMI912207A0 ITMI912207A0 (it) 1991-08-05
ITMI912207A1 true ITMI912207A1 (it) 1993-02-05
IT1251151B IT1251151B (it) 1995-05-04

Family

ID=11360538

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI912207A IT1251151B (it) 1991-08-05 1991-08-05 Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati

Country Status (10)

Country Link
US (1) US5503848A (it)
EP (1) EP0526865A1 (it)
JP (1) JPH05255124A (it)
KR (1) KR930003921A (it)
AU (1) AU654027B2 (it)
BR (1) BR9203032A (it)
CA (1) CA2075340A1 (it)
IT (1) IT1251151B (it)
MX (1) MX9204517A (it)
TW (1) TW215903B (it)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1260154B (it) * 1992-07-03 1996-03-28 Lanfranco Callegaro Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn)
IT1263144B (it) * 1993-02-04 1996-08-01 Lanfranco Callegaro Composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei dell'acido ialuronico in associazione con altre sostanze farmacologicamente attive
US6130264A (en) * 1994-10-06 2000-10-10 Xomed Surgical Products, Inc. Synthetic sponge and surgical spear comprising synthetic sponge
US6080092A (en) * 1994-10-06 2000-06-27 Xomed Surgical Products, Inc. Industrial cleaning sponge
IT1282207B1 (it) * 1995-11-20 1998-03-16 Fidia Advanced Biopolymers Srl Sistemi di coltura di cellule staminali di midollo osseo umano in matrici tridimensionali costituiti da esteri dell'acido ialuronico
US6099952A (en) * 1998-02-18 2000-08-08 Xomed Surgical Products, Inc. Medical sponge having mucopolysaccharide coating
US5976150A (en) * 1998-08-25 1999-11-02 Alcon Laboratories, Inc. Intraocular lens injection system
US6120484A (en) * 1999-02-17 2000-09-19 Silverstein; Herbert Otological implant for delivery of medicament and method of using same
EP1369441A4 (en) 2001-01-31 2004-12-08 Seikagaku Kogyo Co Ltd NETWORKED POLYSACCHARIDE SPONGE
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
MXPA05000533A (es) * 2002-08-07 2005-04-19 Medidom Lab Proceso para preparar una formulacion esteril de acido hialuronico de alto peso molecular.
PL377477A1 (pl) * 2002-12-11 2006-02-06 Ferrosan A/S Materiały na bazie żelatyny jako waciki
US7923031B2 (en) * 2004-01-30 2011-04-12 Ferrosan Medical Devices A/S Haemostatic sprays and compositions
CN101001649B (zh) * 2004-07-09 2011-08-31 弗罗桑医疗设备公司 包括透明质酸的止血组合物及其制备方法
JP2006342207A (ja) * 2005-06-07 2006-12-21 Toshiba Corp 発泡材料組成物、発泡材料、および発泡材料の再生方法
WO2008027904A2 (en) 2006-08-28 2008-03-06 Rexaderm, Inc. Dry wound dressing and drug delivery system
US8257455B2 (en) 2007-07-30 2012-09-04 Korea Institute Of Machinery & Materials Plasma burner and diesel particulate filter trap
WO2009109194A2 (en) * 2008-02-29 2009-09-11 Ferrosan A/S Device for promotion of hemostasis and/or wound healing
RU2499592C2 (ru) 2008-04-21 2013-11-27 Отономи, Инк. Фармацевтическая композиция для лечения ушных заболеваний
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
US8030297B2 (en) 2008-05-14 2011-10-04 Otonomy, Inc. Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders
US8648119B2 (en) * 2008-05-23 2014-02-11 Otonomy, Inc. Controlled release immunomodulator compositions and methods for the treatment of otic disorders
US8846770B2 (en) * 2008-06-18 2014-09-30 Otonomy, Inc. Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
WO2010011466A2 (en) * 2008-06-27 2010-01-28 Otonomy, Inc. Controlled-release cns modulating compositions and methods for the treatment of otic disorders
US8349353B2 (en) * 2008-06-27 2013-01-08 Otonomy, Inc. Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders
MX2011000545A (es) * 2008-07-14 2011-02-24 Otonomy Inc Composiciones de liberacion controlada para la modulacion de apoptosis y metodos para el tratamiento de trastornos oticos.
US8784870B2 (en) 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US8399018B2 (en) * 2008-07-21 2013-03-19 Otonomy, Inc. Controlled release ion channel modulator compositions and methods for the treatment of otic disorders
US8496957B2 (en) * 2008-07-21 2013-07-30 Otonomy, Inc Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
US20100016450A1 (en) * 2008-07-21 2010-01-21 Otonomy, Inc. Controlled release delivery devices for the treatment of otic disorders
CN102105133B (zh) * 2008-07-21 2015-06-17 奥德纳米有限公司 控制释放型耳结构调节和先天性免疫系统调节组合物以及治疗耳部病症的方法
AU2009307825A1 (en) 2008-10-22 2010-04-29 Rick FRIEDMAN Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor
EP2474569A4 (en) * 2009-09-02 2014-03-19 Terumo Corp POROUS STRUCTURE
CN104159527B (zh) 2012-03-06 2017-04-12 弗罗桑医疗设备公司 包含止血糊剂的压力容器
BR112014030962A2 (pt) 2012-06-12 2017-06-27 Ferrosan Medical Devices As métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático
JP2015533190A (ja) 2012-10-09 2015-11-19 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ 修飾されたヒアルロン酸誘導体およびその使用
WO2014202760A2 (en) 2013-06-21 2014-12-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
EA201690323A1 (ru) 2013-08-27 2016-07-29 Отономи, Инк. Способы лечения заболеваний уха у детей
BR112016013322B1 (pt) 2013-12-11 2020-07-21 Ferrosan Medical Devices A/S métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
BR112017007466B1 (pt) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
EP3237041B1 (en) 2014-12-24 2020-01-29 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
WO2017005590A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
CN109328058A (zh) 2016-07-27 2019-02-12 株式会社利他药业 口腔粘膜贴附材料及其制造方法
US11040004B2 (en) 2016-09-16 2021-06-22 Otonomy, Inc. Otic gel formulations for treating otitis externa
AU2019266529B2 (en) 2018-05-09 2024-05-23 Ethicon Inc. Method for preparing a haemostatic composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2915309A1 (de) * 1979-04-14 1980-10-30 Behringwerke Ag Verfahren zur bestimmung von anti-hyaluronidase und hierfuer verwendbares mittel
US4490351A (en) * 1982-03-15 1984-12-25 Children's Hospital Medical Center Methods of treating disorders of an eye with liquid perfluorocarbons
IE57931B1 (en) * 1983-10-11 1993-05-19 Fidia Spa Hyaluronic acid fractions having pharmaceutical activity,methods for preparation thereof,and pharmaceutical compositions containing the same
CA1295796C (en) * 1984-03-27 1992-02-18 Conrad Whyne Biodegradable matrix and methods for producing same
SE8501022L (sv) * 1985-03-01 1986-09-02 Pharmacia Ab Format alster och forfarande for dess framstellning
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
FR2650180B1 (fr) * 1989-07-31 1995-03-03 Chisso Corp Procede de production d'une feuille facilement soluble dans l'eau a base d'acide hyaluronique ou de hyaluronate et feuille ainsi obtenue

Also Published As

Publication number Publication date
MX9204517A (es) 1993-03-01
US5503848A (en) 1996-04-02
TW215903B (it) 1993-11-11
AU654027B2 (en) 1994-10-20
AU2084092A (en) 1993-02-11
ITMI912207A0 (it) 1991-08-05
CA2075340A1 (en) 1993-02-06
BR9203032A (pt) 1993-03-30
EP0526865A1 (en) 1993-02-10
IT1251151B (it) 1995-05-04
KR930003921A (ko) 1993-03-22
JPH05255124A (ja) 1993-10-05

Similar Documents

Publication Publication Date Title
ITMI912207A1 (it) Materiale spugnoso essenzialmente costituito da acido ialuronico, o suoi derivati
FI942894L (fi) Hyaluronihappojohdannaisia sisältävä kuitukangasmateriaali
NO910118D0 (no) Hydrokolloid-basert materiale.
DE69103565D1 (de) Rollenförderer.
DE69105863D1 (de) Fördersystem.
ITTO910567A1 (it) Derivati carbostirilici.
ITTO920719A1 (it) Derivati benzopiranici
DE59100325D1 (de) Schneckenförderer.
BR9101638A (pt) Resina formadora de pegajosidade,processo para sua preparacao bem como usada mesma e composicao adesiva
DE69105888D1 (de) Schneckenförderer.
IT1178356B (it) Elemento di montatura per occhiali, in resina rinforzata da fibre
NO911637D0 (no) Doerkarm.
IT8948247A0 (it) Nuovi derivati di-lisogangliosidi
IT1249212B (it) Derivati diidropirimidotiazinici
ITMI941191A0 (it) 1-b-metil-2-tiol carbapen derivati
DE69111310D1 (de) Polarisiertes elektromagnetisches Relais schmaler Bauform.
ITMI910313A0 (it) Profilato di articolazione particolarmente per vetrata di grande dimensione
ITTO910935A1 (it) Cuscinetto articolato per tiranti snodati.
IT1241410B (it) Derivati triazolo-pirimidinici
IT8928902V0 (it) Telaio componibile, particolarmenteper vetrate
IT9021262A0 (it) Derivati 1,4-benzotiacinici ad attivita' calcio antagonista
BR6802308U (pt) Rolo de fusao para copiadora minolta,da triunfo,modelo ep300re
FI891132A7 (fi) Rullgardinsstaong.
ITMI913397A1 (it) Derivati chinolonici, procedimento di preparazione ed impiego come antibatterici.
KR920004034U (ko) 로울러 스케이트 겸용 로울러 스키

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970828